Carrano Dominic Gabriel 4

What Happened
Dominic Gabriel Carrano, Chief Financial Officer of Veradermics, Inc. (MANE), received a derivative award on 2026-02-03 covering 148,011 underlying shares. The award is reported at an acquisition price of $0.00 (total $0) and is recorded as a grant/award (transaction code A) on the Form 4. This is a time‑based option grant (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-02-03; Form 4 filed: 2026-02-05 (timely filing). Accession: 0001628280-26-005899.
• Instrument: derivative award reported as an option grant for 148,011 shares at $0.00. Reported value: $0.
• Vesting (footnote): 25% vests on Feb 3, 2027 (one year cliff), then the remainder vests in equal monthly installments over the next 36 months, subject to continued service.
• Shares owned following the transaction: not specified in the provided filing.
• No sale or cash exercise accompanied this grant; it is a compensation award.

Context
This filing documents a compensation-related option grant to the CFO. Such grants typically vest over time and do not represent an immediate purchase or sale of stock; they become economically meaningful only as they vest and, if applicable, are exercised. The footnote confirms the multi-year vesting schedule and the continued-service requirement.